PRIME Care Study Shows Patients Whose Clinicians Had Access to the GeneSight® Test Are More Likely to Achieve Remission from Depression
Major depressive disorder (MDD), also known as clinical depression, is a serious and all-too common medical illness, affecting an estimated 21 million U.S. adults, according to the National Institutes for…
Read More